Walkersville, MD (PRWEB) May 11, 2011
Lonza customers from pharmaceutical and biotechnology companies will offer their insights and successes using advancements in the automation of Quality Control Microbiology (QC Micro), featuring Lonza’s MODA™ Solution, at the following conferences across the United States and Europe:
>> Migration to Paperless Microbiological Environmental Monitoring:
Presented by Kjersti Aulie, QC Manager at GE Healthcare, this presentation will be held at the 42nd Annual R3 Nordic Symposium on Monday, May 9 in Oslo, Norway.
>> Strategies for Implementing and Maintaining a Robust and Compliant Aseptic Gowning Qualification, Re-Qualification, and Routine Monitoring Program:
Presented by Dominick Villani, Manager of QC Microbiology at Amylin Pharmaceuticals, this presentation will be held at the PMF Conference on Environmental Monitoring on Monday, May 16 in Las Vegas, Nevada.
>> The Next Generation—Advanced QC Microbiology:
Presented by Nicole Quinlan, Senior Manager-Laboratory Systems at Auxilium Pharmaceuticals, this presentation will be held at the 2nd Annual ACE Forum sponsored by the Institute of Validation Technology (IVT) on Wednesday, June 22 in Philadelphia, Pennsylvania.
Paper-based processes still burden most QC Micro programs: paper scheduling, sharpie pen labeling of sample media, manual reconciliation, paper log book entry, and manual notification on deviations. These steps are labor-intensive, time consuming, and yield duplication of tasks and high error rates. These presentations will demonstrate QC Automation best practices that a growing number of pharmaceutical and biotechnology companies are implementing across their manufacturing facilities.
About MODA™ Solution
More science. Less paper.™ The MODA™ solution strengthens Lonza’s overall Rapid Testing Solutions platform by adding a complementary product offering for quality assurance (QA) and quality control (QC) organizations in the life science industry. The MODA™ solution offers automated data collection, workflow management, on demand analytics and visualization of regulated manufacturing processes, including environmental monitoring (EM), utility testing, and product testing. The MODA™ solution eliminates inefficiencies and reduces error rates inherent with paper-based systems. Further information can be found at http://www.lonza.com/moda
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2010, the company had sales of CHF 2.680 billion. Further information can be found at http://www.lonza.com.